Sanara MedTech (SMTI) Profit After Tax (2010 - 2026)

Sanara MedTech (SMTI) has 16 years of Profit After Tax data on file, last reported at -$354.0 in Q1 2026.

• Quarterly Profit After Tax rose 99.94% year-over-year to -$354.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.8 million (up 80.03% YoY) and the FY2025 annual result came in at -$37.6 million, down 288.72% from the prior year.
• Profit After Tax advanced to -$354.0 in Q1 2026, from -$1.6 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $834493.0 in Q3 2025 to a low of -$9.7 million in Q4 2024.
• A 5-year average of -$1.8 million and a median of -$1.5 million in 2022 frame the typical range for Profit After Tax.
• Annual changes were most pronounced in 2024 — Profit After Tax sank 7583.63% — and 2025, when it jumped 562.35%.
• Tracing SMTI's Profit After Tax over 5 years: stood at -$4.2 million in 2022, then surged by 96.98% to -$125739.0 in 2023, then slumped by 7583.63% to -$9.7 million in 2024, then surged by 83.33% to -$1.6 million in 2025, then jumped by 99.98% to -$354.0 in 2026.
• The last three Profit After Tax figures came in at -$354.0 (Q1 2026), -$1.6 million (Q4 2025), and $834493.0 (Q3 2025), per Business Quant data.